GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

LRRK2 inhibitor 6 [PMID: 40353293]   Click here for help

GtoPdb Ligand ID: 13902

Compound class: Synthetic organic
Comment: This is a small molecule, orally bioavailable inhibitor of leucine rich repeat kinase 2 (LRRK2) [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 3
Rotatable bonds 4
Topological polar surface area 88.77
Molecular weight 346.39
XLogP 0.73
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN1C=C(NC2=NC(=C3C=CNC3=N2)N[C@H]4CCC5=C4C=CC=C5)N=N1
Isomeric SMILES CN1C=C(N=N1)NC2=NC(N[C@@H]3C4=C(CC3)C=CC=C4)=C5C=CNC5=N2
InChI InChI=1S/C18H18N8/c1-26-10-15(24-25-26)21-18-22-16-13(8-9-19-16)17(23-18)20-14-7-6-11-4-2-3-5-12(11)14/h2-5,8-10,14H,6-7H2,1H3,(H3,19,20,21,22,23)/t14-/m0/s1
InChI Key ZQSBNCTWGKRISE-AWEZNQCLSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
Inhibits wild-type LRRK2 and mutant LRRK2G2019S (which in humans is a genetic risk factor for Parkinson's disease) at nanomolar concentrations [1]. Low potency inhibition of TTK (IC50 5.2 μM).
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
leucine rich repeat kinase 2 Hs Inhibitor Inhibition 7.5 pIC50 - 1
pIC50 7.5 (IC50 3.5x10-8 M) [1]